MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE TO COCAINE SELF-ADMINISTRATION Release Date: November 9, 1999 NOTICE: DA-00-001 RFP NUMBER: N01DA-0-8801 National Institute on Drug Abuse Under the upcoming solicitation, The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the in-house capability to develop methodologies and to perform in vivo rodent behavioral pharmacology studies of potential pharmacotherapies for cocaine dependence using a cocaine self-administration reinstatement model. The Contractor will be blinded to the identity of proprietary test compounds, the compounds will be evaluated in established assays, and the resulting data will be utilized by the NIDA Cocaine Treatment Discovery Program. The successful offeror must indicate possession of current DEA registration for Schedules II-V substances prior to award and apply for Schedule I registration. NIDA anticipates awarding a cost-reimbursement, four-year contract with optional quantities. RFP No. N01DA-0-8801 will be available electronically on or about November 29, 1999, and may be accessed through the Internet at the following address: (URL:http://www.nida.nih.gov/RFP/RFPList.html). All information required for the submission of an offer will be contained in the electronic RFP package. Response to the RFP will be due on or about February 7, 2000. Any responsible offeror may submit a proposal that will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Patricia W. Mummaugh, Contract Specialist Electronic Mail Address: pm69j@nih.gov Telephone: (301) 443-6677 FAX: (301) 443-7595.
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |